Cargando…
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression
Depression is a highly prevalent mood disorder and one of the major health concerns in modern society. Moreover, it is characterized by a high prevalence of coexistence with many other diseases including metabolic disorders such as type 2 diabetes mellitus (T2DM) and obesity. Currently used antidepr...
Autores principales: | Detka, Jan, Głombik, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413152/ https://www.ncbi.nlm.nih.gov/pubmed/34003475 http://dx.doi.org/10.1007/s43440-021-00274-8 |
Ejemplares similares
-
Changes in regulators of lipid metabolism in the brain: a study of animal models of depression and hypothyroidism
por: Głombik, Katarzyna, et al.
Publicado: (2022) -
Venlafaxine and L-Thyroxine Treatment Combination: Impact on Metabolic and Synaptic Plasticity Changes in an Animal Model of Coexisting Depression and Hypothyroidism
por: Głombik, Katarzyna, et al.
Publicado: (2021) -
Brain Metabolic Alterations in Rats Showing Depression-Like and Obesity Phenotypes
por: Głombik, Katarzyna, et al.
Publicado: (2019) -
Impaired Brain Energy Metabolism: Involvement in Depression and Hypothyroidism
por: Głombik, Katarzyna, et al.
Publicado: (2020) -
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)